Healthcare Intelligence
Health Economics & Outcomes Research
Real-time intelligence, expert analysis, and verified research for the Health Economics & Outcomes Research industry. Stay ahead in 3 minutes a day.
Stay ahead of Health Economics & Outcomes Research in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
ISPOR 2024 Europe: AI Integration in HEOR Takes Center Stage
International conference highlights AI's growing role in health economics research and real-world evidence generation.
Read full articleNovo Nordisk Publishes Cost-Effectiveness Study for Wegovy in Heart Disease
New HEOR data shows obesity drug Wegovy demonstrates favorable cost-effectiveness ratio for cardiovascular outcomes.
Read full articleFDA Proposes New Guidelines for Real-World Evidence in Drug Approvals
Regulatory guidance aims to standardize use of real-world data in pharmaceutical outcomes research and submissions.
Read full articleMerck Invests $50M in Digital HEOR Platform Partnership
Pharmaceutical giant partners with health tech firm to enhance patient outcomes tracking and economic modeling.
Read full articleStudy: Value-Based Contracts Show Mixed Results in 2024 Analysis
New research reveals challenges and opportunities in pharmaceutical value-based pricing agreements across markets.
Read full articleUK NICE Updates Methods for Health Technology Assessment
National Institute revises HTA guidelines to include broader societal value considerations in drug evaluations.
Read full articleRoche Launches Global HEOR Fellowship Program for 2025
Initiative aims to develop next generation of health economics researchers with focus on oncology outcomes.
Read full articleReport: HEOR Job Market Grows 23% as Demand for Evidence Increases
Industry analysis shows rising demand for health economics professionals amid focus on value-based healthcare.
Read full articleISPOR 2024 Europe: AI Integration in HEOR Takes Center Stage
International conference highlights AI's growing role in health economics research and real-world evidence generation.
Read full articleNovo Nordisk Publishes Cost-Effectiveness Study for Wegovy in Heart Disease
New HEOR data shows obesity drug Wegovy demonstrates favorable cost-effectiveness ratio for cardiovascular outcomes.
Read full articleFDA Proposes New Guidelines for Real-World Evidence in Drug Approvals
Regulatory guidance aims to standardize use of real-world data in pharmaceutical outcomes research and submissions.
Read full articleMerck Invests $50M in Digital HEOR Platform Partnership
Pharmaceutical giant partners with health tech firm to enhance patient outcomes tracking and economic modeling.
Read full articleStudy: Value-Based Contracts Show Mixed Results in 2024 Analysis
New research reveals challenges and opportunities in pharmaceutical value-based pricing agreements across markets.
Read full articleUK NICE Updates Methods for Health Technology Assessment
National Institute revises HTA guidelines to include broader societal value considerations in drug evaluations.
Read full articleRoche Launches Global HEOR Fellowship Program for 2025
Initiative aims to develop next generation of health economics researchers with focus on oncology outcomes.
Read full articleReport: HEOR Job Market Grows 23% as Demand for Evidence Increases
Industry analysis shows rising demand for health economics professionals amid focus on value-based healthcare.
Read full articleStay ahead of Health Economics & Outcomes Research in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.